These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27652260)

  • 1. Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai.
    Chen Y; Yuan Z; Shen X; Wu J; Wu Z; Xu B
    Biomed Res Int; 2016; 2016():2628913. PubMed ID: 27652260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
    Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
    Shen X; Li J; Gao Q; Xu B; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.
    Chen Y; Yuan Z; Shen X; Wu J; Wu Z; Xu B
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis.
    Dowdy DW; van't Hoog A; Shah M; Cobelens F
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):647-54. PubMed ID: 24903933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
    Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 9. Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis.
    He GX; van den Hof S; Borgdorff MW; van der Werf MJ; Cheng SM; Hu YL; Zhang LX; Wang LX
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):884-9. PubMed ID: 20550773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance to second-line drugs among persons with tuberculosis in the United States.
    Ershova JV; Kurbatova EV; Moonan PK; Cegielski JP
    Clin Infect Dis; 2012 Dec; 55(12):1600-7. PubMed ID: 22942206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
    Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection.
    Bonnet M; Pardini M; Meacci F; Orrù G; Yesilkaya H; Jarosz T; Andrew PW; Barer M; Checchi F; Rinder H; Orefici G; Rüsch-Gerdes S; Fattorini L; Oggioni MR; Melzer J; Niemann S; Varaine F
    PLoS One; 2011; 6(8):e23081. PubMed ID: 21886778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.
    Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
    Int J Infect Dis; 2020 Jul; 96():390-397. PubMed ID: 32353546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
    Şimşek H; Tarhan G; Cesur S
    Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
    Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
    Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.
    Ershova JV; Kurbatova EV; Moonan PK; Cegielski JP
    Clin Infect Dis; 2014 Aug; 59(4):465-72. PubMed ID: 24846639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.